Group 1 - AdvanSix reported quarterly earnings of 0.88pershare,exceedingtheZacksConsensusEstimateof0.66 per share, and showing a significant improvement from a loss of 0.36pershareayearago,resultinginanearningssurpriseof33.33398.19 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 11.33% and increasing from 322.91millioninthesamequarterlastyear[2]−Overthelastfourquarters,AdvanSixhassurpassedconsensusEPSestimatesthreetimesandtoppedconsensusrevenueestimatesthreetimesaswell[2]Group2−Thestockhasunderperformedthemarket,losingabout5.30.26 on revenues of 388.8million,andforthecurrentfiscalyear,itis1.91 on revenues of $1.56 billion [7] Group 3 - The Zacks Industry Rank indicates that the Chemical - Specialty industry is currently in the bottom 41% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - AdvanSix has a Zacks Rank of 2 (Buy), indicating expectations for the stock to outperform the market in the near future based on favorable estimate revisions [6]